Top picks in English

New Zealand CEO to open the door to the US - chairman has three demands

The new CEO of Zealand Pharma was appointed due to his experience with launching products in the US - a market the Danish company is about to enter. And chairman Martin Nicklasson has more tasks for the new executive.
Emmanuel Dulac takes position in Zealand Pharma as of April 22. | Foto: Zealand Pharma
Emmanuel Dulac takes position in Zealand Pharma as of April 22. | Foto: Zealand Pharma
af ULRICH QUISTGAARD

Danish Zealand Pharma has appointed Emmanuel Dulac from US-based Alnylam as new CEO. Although the job change entails a move across the Atlantic, Dulac will most likely continue to spend much time in the US - a market Zealand Pharma is preparing to enter.

Allerede abonnent?Log ind her

Læs hele artiklen

Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

Med din prøveperiode får du:

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
    • Skal indeholde mindst 8 tegn samt tre af disse: Store bogstaver, små bogstaver, tal, symboler
    Skal indeholde mindst 2 tegn
    Skal indeholde mindst 2 tegn

    Få fuld adgang til dig og dine kollegaer

    Start et gratis virksomhedsprøveabonnement

    Del artikel

    Relaterede artikler

    Tilmeld dig vores nyhedsbrev

    Vær på forkant med udviklingen. Få den nyeste viden fra branchen med vores nyhedsbrev.

    Nyhedsbrevsvilkår

    Forsiden lige nu

    Læs også

    Job